Information  X 
Enter a valid email address

Kromek Group PLC (KMK)

  Print      Mail a friend

Thursday 31 January, 2019

Kromek Group PLC

Total Voting Rights

RNS Number : 7179O
Kromek Group PLC
31 January 2019
 

31 January 2019

 

Kromek Group plc

 

("Kromek" or the "Company") 

 

Total Voting Rights

 

In conformity with the FCA's Disclosure and Transparency Rules, Kromek confirms the following:

 

As at 31 January 2019 Kromek's issued share capital consists of 260,550,618 ordinary shares of 1 pence each ("Ordinary Shares"). The Company holds no Ordinary Shares in treasury and accordingly the total number of current voting rights in the Company is 260,550,618 Ordinary Shares.

 

The above figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Enquiries:

 

Kromek Group plc


Arnab Basu, CEO

Derek Bulmer, CFO

+44 (0)1740 626 060



Cenkos Securities plc


Max Hartley (NOMAD)

Julian Morse (Sales)

+44 (0)20 7397 8900

 

Cantor Fitzgerald Europe (Joint Broker)

 

+44 (0)20 7894 7000

Philip Davies

Will Goode




Luther Pendragon Ltd


Harry Chathli, Claire Norbury, Alexis Gore

+44 (0)20 7618 9100

 

About Kromek Group plc

 

Kromek Group plc is a UK technology Group (global HQ in County Durham) and a leading developer of high performance radiation detection products based on cadmium zinc telluride ("CZT") and other advanced technologies. Using its core technology platforms, Kromek designs, develops and produces x-ray and gamma ray imaging and radiation detection products for the medical, security screening and nuclear markets.

The Group's products provide high resolution information on material composition and structure and are used in multiple applications, ranging from the identification of cancerous tissues to hazardous materials, such as explosives, and the analysis of radioactive materials.

The Group's business model provides a vertically integrated technology offering to customers, from radiation detector materials to finished products or detectors, including software, electronics and application specific integrated circuits ("ASICs").

The Group has operations in the UK and US (California and Pennsylvania), and is selling internationally through a combination of distributors and direct OEM sales.

Currently, the Group has over one hundred full time employees across its global operations. Further information on Kromek Group is available at www.kromek.com and https://twitter.com/kromekgroup.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVRXFLFXKFFZBBD

a d v e r t i s e m e n t